These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. New year, new option: Cyclo-Provera awaits word. Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212 [TBL] [Abstract][Full Text] [Related]
29. Injectable contraception. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1980 Dec; 14(6):1-3. PubMed ID: 12310087 [TBL] [Abstract][Full Text] [Related]
30. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study. Kaplan I; Ross D; Hilton F; Morgenstern D; Wolter K Contraception; 2016 Oct; 94(4):314-20. PubMed ID: 27241898 [TBL] [Abstract][Full Text] [Related]
31. Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi. Burke HM; Packer C; Buluzi M; Healy E; Ngwira B Contraception; 2018 Nov; 98(5):405-410. PubMed ID: 29706227 [TBL] [Abstract][Full Text] [Related]
32. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland]. Lech MM Wiad Lek; 2003; 56(7-8):362-8. PubMed ID: 14969166 [TBL] [Abstract][Full Text] [Related]
33. The contraceptive use of Depo-Provera in U.S. adolescents. Pinkston Koenigs LM; Miller NH J Adolesc Health; 1995 May; 16(5):347-9. PubMed ID: 7662682 [TBL] [Abstract][Full Text] [Related]
34. Injectable contraception: the USA perspective. Kaunitz AM IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920 [TBL] [Abstract][Full Text] [Related]